SWOG clinical trial number
SWOG-7514

VP-16-213 in Adults with Metastatic Adenocarcinoma of the Breast

Closed
Abbreviated Title
VP-16-213 in Adults with Metastatic Adenocarcinoma of the Breast
Activated
08/08/1975
Closed
02/01/1978

Publication Information Expand/Collapse

1982

Phase II evaluation of VP-16-213 in patients with advanced breast cancer

CB Vaughn Oncology Digest 5-6

1981

Phase II evaluation of 4-demethyl-E-pipodophyl-lotoxin-B- dethylidone glucoside (VP-16-213) (NSC-14150) in patients with advanced breast cancer: A Southwest Oncology Group study

CB Vaughn;F Panettiere;T Thigpen;R Bottomley;B Hoogstraten;B Samal Cancer Treat Rep 65:443-445